Odyssey Health, Inc. Income Statement
ODYY|6 years of annual SEC 10-K data (FY2015-FY2021)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 6 fiscal years. All figures from audited SEC 10-K filings.
Revenue decreased 85.4% from FY2015 to FY2016.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -147.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2021 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|
| Revenue | - | $0 | $0 | $0 | $37.5K | $257.2K |
| Cost of Revenue | - | $0 | $0 | $0 | $20.3K | $228.5K |
| Gross Profit | - | $0 | $0 | $0 | $17.2K | $28.7K |
| SG&A Expense | $4.8M | $23.4M | $289.0K | $167.6K | $90.7K | $184.6K |
| R&D Expense | $1.6M | $23.0M | - | - | - | - |
| Operating Income | -$15.9M | -$23.6M | -$420.4K | -$167.6K | -$73.6K | -$155.9K |
| Interest Expense | $1.1M | $70.3K | $62.7K | $30.3K | $12.5K | $4.8K |
| Income Tax | $0 | $0 | - | - | - | - |
| Net Income | -$16.9M | -$23.4M | -$483.1K | -$197.8K | -$86.1K | -$160.7K |
| EPS (Basic) | -$0.05 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding | 88.6M | 61.4M | 114.8M | 114.8M | 114.8M | 114.8M |
| Gross Margin | - | - | - | - | 45.8% | 11.2% |
| Operating Margin | - | - | - | - | -196.4% | -60.6% |
| Profit Margin | - | - | - | - | -229.9% | -62.5% |